Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Division of Immunobiology, Cincinnati Children's Hospital Medical Center (CCHMC), Cincinnati, Ohio, USA.
JCI Insight. 2018 Mar 22;3(6):93626. doi: 10.1172/jci.insight.93626.
Nonalcoholic fatty liver disease (NAFLD), a metabolic predisposition for development of hepatocellular carcinoma (HCC), represents a disease spectrum ranging from steatosis to steatohepatitis to cirrhosis. Acox1, a rate-limiting enzyme in peroxisomal fatty acid β-oxidation, regulates metabolism, spontaneous hepatic steatosis, and hepatocellular damage over time. However, it is unknown whether Acox1 modulates inflammation relevant to NAFLD pathogenesis or if Acox1-associated metabolic and inflammatory derangements uncover and accelerate potential for NAFLD progression. Here, we show that mice with a point mutation in Acox1 (Acox1Lampe1) exhibited altered cellular metabolism, modified T cell polarization, and exacerbated immune cell inflammatory potential. Further, in context of a brief obesogenic diet stress, NAFLD progression associated with Acox1 mutation resulted in significantly accelerated and exacerbated hepatocellular damage via induction of profound histological changes in hepatocytes, hepatic inflammation, and robust upregulation of gene expression associated with HCC development. Collectively, these data demonstrate that β-oxidation links metabolism and immune responsiveness and that a better understanding of peroxisomal β-oxidation may allow for discovery of mechanisms central for NAFLD progression.
非酒精性脂肪性肝病 (NAFLD) 是肝细胞癌 (HCC) 发展的代谢倾向,代表了从脂肪变性到脂肪性肝炎再到肝硬化的疾病谱。过氧化物酶体脂肪酸β-氧化的限速酶 Acox1 调节代谢、自发性肝脂肪变性和随时间推移的肝细胞损伤。然而,尚不清楚 Acox1 是否调节与 NAFLD 发病机制相关的炎症,或者 Acox1 相关的代谢和炎症紊乱是否揭示并加速了 NAFLD 进展的潜力。在这里,我们表明,过氧化物酶体脂肪酸β-氧化的限速酶 Acox1 中的点突变 (Acox1Lampe1) 表现出改变的细胞代谢、改变的 T 细胞极化和加剧的免疫细胞炎症潜力。此外,在短暂的肥胖饮食应激下,与 Acox1 突变相关的 NAFLD 进展导致通过诱导肝细胞、肝炎症和与 HCC 发展相关的基因表达的显著增加的深刻组织学变化,显著加速和加剧肝细胞损伤。总的来说,这些数据表明β-氧化将代谢和免疫反应联系起来,更好地理解过氧化物酶体β-氧化可能为发现 NAFLD 进展的核心机制提供线索。